All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

184

Reset

184 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • IAM1363Phase 21 trial

    Iambic Therapeutics, Inc · HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer

  • IMT-009Phase 21 trial

    Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer

  • INV-6452Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer

  • INX-315Phase 21 trial

    Incyclix Bio · Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor

  • IOV-5001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Advanced Solid Tumors, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer (TNBC)

  • JAB-2485Aurora A inhibitorPhase 21 trial

    Jacobio Pharmaceuticals Co., Ltd. · Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC

  • KC1086Phase 21 trial

    Beijing Konruns Pharmaceutical Co., Ltd. · HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

  • KVA12123Phase 21 trial

    Kineta Inc. · Cancer, Solid Tumor, Melanoma

  • LG00313112Phase 21 trial

    LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • LP-184Phase 21 trial

    Lantern Pharma Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, GBM

  • MDSY-1240Phase 21 trial

    Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic

  • MDX2001Phase 21 trial

    ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer

  • MT-4561Phase 21 trial

    Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer

  • Nab-placlitaxelPhase 21 trial

    BioNTech SE · Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers

  • NadunolimabCAN04Phase 21 trial

    Cantargia AB · Triple Negative Breast Cancer

  • NBQ72SQBS10072SPhase 21 trial

    Nantong Bencao Quadriga Medical Technology Co. Ltd. · Breast Cancer

  • NUV-1511Phase 21 trial

    Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • PF-0704091Phase 21 trial

    Pfizer · Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer

  • PMD-026Phase 21 trial

    Phoenix Molecular Designs · Metastatic Breast Cancer

  • QLS1304Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · Advanced ER+/HER2- Breast Cancer

  • RO0091978Phase 21 trial

    Roche (Genentech) · Metastatic Breast Cancer

  • Sequential EpirubicinPhase 21 trial

    RemeGen Co., Ltd. · Breast Cancer

  • SMP-656Phase 21 trial

    Chengdu SciMount Pharmatech Co., Ltd. · HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)

  • SNS-101anti-VISTAPhase 21 trial

    Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer

  • ST-067Phase 21 trial

    Simcha IL-18, Inc. · Cancer, Solid Tumor, Melanoma

  • ST101Phase 21 trial

    Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer

  • SYHX2011Phase 21 trial

    CSPC Ouyi Pharmaceutical Co., Ltd. · Advanced Breast Cancer

  • SYS6023Phase 21 trial

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Breast Cancer

  • TenalisibRP6530Phase 21 trial

    Rhizen Pharmaceuticals SA · Triple Negative Breast Cancer (TNBC)

  • TER-2013Phase 21 trial

    Terremoto Biosciences Inc. · Breast Cancer, Endometrial Cancer, Ovarian Cancer

  • TQB3126Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Breast Cancer

  • TUB-030Phase 21 trial

    Gilead Sciences · Advanced Solid Tumors, HNSCC, SCLC

  • VB15010Phase 21 trial

    Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast

  • VLS-1488Phase 21 trial

    Volastra Therapeutics, Inc. · Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer

NewerPage 4 of 4

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.